Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aytu BioScience (AYTU) stocks

Learn how to easily invest in Aytu BioScience stocks.

Aytu BioScience is a drug manufacturers-specialty & generic business based in the US. Aytu BioScience stocks (AYTU.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.54 – the same closing value as a week prior. Aytu BioScience employs 175 staff and has a trailing 12-month revenue of around $92.7 million.

How to buy stocks in Aytu BioScience

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AYTU – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Aytu BioScience stock price (NASDAQ:AYTU)

Use our graph to track the performance of AYTU stocks over time.

Aytu BioScience shares at a glance

Information last updated 2022-10-02.
Latest market close$0.19
52-week range$0.18 - $2.93
50-day moving average $0.32
200-day moving average $0.80
Wall St. target price$5.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-4.24

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$0 if conditions met, else $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
4.1 / 5
min $1.00, max 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Finder Rating:
3.9 / 5
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends October 31, 2022.

Compare up to 4 providers

Is it a good time to buy Aytu BioScience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Aytu BioScience price performance over time

Historical closes compared with the close of $0.19 from 2022-09-30

1 week (2022-09-26) 0.19
1 month (2022-09-02) -17.03%
3 months (2022-07-01) -71.64%
6 months (2022-04-01) -82.08%
1 year (2021-10-01) -93.56%
2 years (2020-10-02) -84.30%
3 years (2019-10-03) 1.09
5 years (2017-10-03) 4.14

Aytu BioScience financials

Revenue TTM $92.7 million
Gross profit TTM $29.2 million
Return on assets TTM -12.62%
Return on equity TTM -109.13%
Profit margin -120.24%
Book value $1.83
Market capitalisation $11.6 million

TTM: trailing 12 months

Aytu BioScience share dividends

We're not expecting Aytu BioScience to pay a dividend over the next 12 months.

Have Aytu BioScience's shares ever split?

Aytu BioScience's shares were split on a 1:10 basis on 9 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu BioScience shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aytu BioScience shares which in turn could have impacted Aytu BioScience's share price.

Aytu BioScience share price volatility

Over the last 12 months, Aytu BioScience's shares have ranged in value from as little as $0.18 up to $2.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu BioScience's is -0.2737. This would suggest that Aytu BioScience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu BioScience has bucked the trend.

Aytu BioScience overview

Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.

Stocks similar to Aytu BioScience

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site